These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22859060)

  • 1. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
    Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
    Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of cd39/entpd1 results in hepatic insulin resistance.
    Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
    Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
    Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
    Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
    Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
    Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
    Künzli BM; Nuhn P; Enjyoji K; Banz Y; Smith RN; Csizmadia E; Schuppan D; Berberat PO; Friess H; Robson SC
    Gastroenterology; 2008 Jan; 134(1):292-305. PubMed ID: 18036594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.
    Shuai C; Xia GQ; Yuan F; Wang S; Lv XW
    Eur J Pharmacol; 2021 Aug; 905():174198. PubMed ID: 34033815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic dysregulation in pulmonary hypertension.
    Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disordered cellular migration and angiogenesis in cd39-null mice.
    Goepfert C; Sundberg C; Sévigny J; Enjyoji K; Hoshi T; Csizmadia E; Robson S
    Circulation; 2001 Dec; 104(25):3109-15. PubMed ID: 11748109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.
    Friedman DJ; Rennke HG; Csizmadia E; Enjyoji K; Robson SC
    Diabetes; 2007 Sep; 56(9):2371-9. PubMed ID: 17473221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
    Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
    Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.
    Beldi G; Wu Y; Sun X; Imai M; Enjyoji K; Csizmadia E; Candinas D; Erb L; Robson SC
    Gastroenterology; 2008 Nov; 135(5):1751-60. PubMed ID: 18804472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of cochlear function in Cd39 deficient mice.
    Vlajkovic SM; Housley GD; Thorne PR; Gupta R; Enjyoji K; Cowan PJ; Charles Liberman M; Robson SC
    Hear Res; 2009 Jul; 253(1-2):77-82. PubMed ID: 19327391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated allergic airway inflammation in Cd39 null mice.
    Idzko M; K Ayata C; Müller T; Dürk T; Grimm M; Baudiß K; Vieira RP; Cicko S; Boehlke C; Zech A; Sorichter S; Pelletier J; Sévigny J; Robson SC
    Allergy; 2013 Apr; 68(4):472-80. PubMed ID: 23452076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
    Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
    PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.
    Schmelzle M; Duhme C; Junger W; Salhanick SD; Chen Y; Wu Y; Toxavidis V; Csizmadia E; Han L; Bian S; Fürst G; Nowak M; Karp SJ; Knoefel WT; Esch JSA; Robson SC
    Ann Surg; 2013 Apr; 257(4):693-701. PubMed ID: 23474584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
    Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.